insights_auto
Outlook: 53.3% bullish·13.3% bearish
Go to analysischevron_right
ELVN:NASDAQ
Enliven Therapeutics Inc
$40.63
arrow_downward
-1.76%(-0.73) 1D
$40.63
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 14 analysts giving stock ratings to ELVN in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for ELVN in the last 3 months.
Highest
Current $40.63
$82.00 (+101.82%)
Average
$73.67 (+81.32%)
Lowest
$65.00 (+59.98%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Phil Nadeau TD Cowen | Buy | Maintained | - | - | 10/07/2026 |
Etzer Darout Barclays | Buy | Maintained | $78.00 | +92% | 10/07/2026 |
Andy Hsieh William Blair | Buy | Reiterated | - | - | 10/06/2026 |
Sean Laaman Morgan Stanley | Buy | Initiated | $70.00 | +72.3% | 10/05/2026 |
Priyanka Grover J.P. Morgan | Buy | Initiated | $75.00 | +84.6% | 10/01/2026 |
Salim Syed Mizuho Securities | Buy | Maintained | $73.00 | +79.7% | 08/17/2026 |
Dara Azar Stifel Nicolaus | Buy | Reiterated | $82.00 | +101.8% | 08/13/2026 |
Sam Slutsky LifeSci Capital | Buy | Reiterated | $70.00 | +72.3% | 08/08/2026 |
Colleen M. Kusy Robert W. Baird | Buy | Maintained | $75.00 | +84.6% | 08/06/2026 |
Boris Peaker JonesTrading | Buy | Reiterated | $70.00 | +72.3% | 08/06/2026 |
Michael Schmidt Guggenheim | Buy | Maintained | $78.00 | +92% | 08/05/2026 |
Salveen Richter Goldman Sachs | Buy | Reiterated | $80.00 | +96.9% | 08/05/2026 |
Kaveri Pohlman Clear Street | Buy | Reiterated | $68.00 | +67.4% | 08/06/2026 |
Robert Burns H.C. Wainwright | Buy | Reiterated | $65.00 | +60% | 07/09/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $59.00 | +45.2% | 06/15/2026 |
Soumit Roy JonesTrading | Buy | Maintained | $45.00 | +10.8% | 04/06/2026 |